Clinical Trial Update: The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver: [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early trial investigating Henggliejin for improving fatty liver in people with type 2 diabetes and nonalcoholic fatty liver disease; the study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Henggliejin

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: NAFLD, Diabete Type 2 | EARLY_Phase 1 | Status: NOT_YET_RECRUITING